References
- Coluccia M, Correale M, Fanizzi FP, Giordano D, Maresca L, Mariggiò MA, et al. 1984. Mutagenic activity of some platinum complexes: chemical properties and biological activity. Toxicol Environ Chem. 8:1–8.
- Gunduz T, Gunduz N, Sakiyan I. 1994. A new method for synthesis of manganese(III) acetate dihydrate. Synth React Inorg Met-Org Chem. 24:519–524
- Handique AK, Aprem H. 1997. Antimutagenic activity of tryptophan and alanine. Curr Sci. 72:578–580.
- Hartmann M, Hartwig A. 1998. Disturbance of DNA damage recognition after UV-irradiation by nickel(II) and cadmium(II) in mammalian cells. Carcinogenesis. 19:617–621.
- Irie R, Noda K, Ito Y, Matsumoto N, Katsuki T. 1991. Catalytic asymmetric epoxidation of unfunctionalized olefins using chiral (salen) manganese(III) complexes. Tetrahedron Asymmetry. 2:481–494.
- Jacobsen EN, Zhang W, Muci AR, Ecker JR, Deng L. 1991. Highly enantioselective epoxidation catalysts derived from 1,2-diaminocyclohexane. J Am Chem Soc. 113:7063–7064.
- Kuhl A, Hahn MG, Dumić M, Mittendorf J. 2005. Alicyclic beta-amino acids in medicinal chemistry. Amino Acids. 29:89–100.
- Landini D, Maia A, Pina C. 2004. Ring opening reactions of 1,2-epoxides catalyzed by complexes of polyether ligands with metal halides in low polarity solvents. Comparison with heterogeneous systems. Arkivoc 3:202–212.
- Liping L, Jinjun Y, Caixia Y, Miaoli Z, Hong H, Zhiwei L, Maolin G. 2011. Ternary oxovanadium (IV) complexes with amino acid- Schiff base and polypyridyl derivatives: Synthesis, characterization, and protein tyrosine phosphatase 1B inhibition. J Inorg Biochem.105:1323–1328.
- McConathy J, Martarello L, Malveaux EJ, Camp VM, Simpson NE, Simpson CP, et al. 2002. Radiolabeled amino acids for tumor imaging with PET: Radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]Fluoro-2-methyl-2-(methylamino)propanoic acid. J Med Chem. 23: 2240–2249.
- McLean M, Dutton MF.1995. Cellular interactions and metabolism of aflatoxin: an update. Pharmacol Ther. 65:163–192.
- Roy MK, Kuwabara Y, Hara K, Watanabe Y, Tamai Y. 2002. Antimutagenic effect of amino acids on the mutagenicity of N-methyl- N’-nitro-N-nitrosoguanidine (MNNG). Biosci Biotech Biochem. 66: 1400–1402.
- Sakiyan I. 2007. Synthesis and characterization of four new manganese(III) complexes and amino acid (L-Aspartic Acid, L-Asparagine, L-Glutamic Acid, L-Glutamine) Schiff bases. Trans Met Chem. 32:131–135.
- Sarı N, PiŞkin N, Öğütcü H, Yetim KN. 2013. Spectroscopic characterization of novel D-aminoacid-Schiff bases and their Cr(III) and Ni(II) complexes as antimicrobial agents. Med Chem Res. 22: 580–587.
- Snow ET. 1992. Mechanistic implications. Pharmacol Ther. 53:31–65.
- Tavares DC, Cecchi AO, Antunes LM, Takahash CS. 1998. Protective effects of the amino acid glutamine and of ascorbic acid against chromosomal damage induced by doxorubicin in mammalian cells. Teratog Carcinog Mutagen. 18:153–161.
- Zasukhina GD, Vasi'eva IM, Mikhal'chik ES, Durnev AD, Gromov SP, Fedorova OA, Alfimov MV. 2003. Antimutagenic and antioxidant activities of crown compounds in comparison with the effects of garlic extract. Bull Exp Biol Med. 135:261–264.